- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Circulating Biomarker for Liquid Biopsy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Abbott Laboratories
Becton, Dickinson and Company
Epigenomics AG
GE Healthcare
Fluxion Biosciences
Biocept
Affymetrix
By Type:
Cell-Free DNA (cfDNA)
Circulating Tumor DNA (ctDNA)
Extracellular Vesicles (EVs)
Circulating Tumor Cells (CTCs)
Others
By Application:
Treatment Monitoring
Therapy Selection
Recurrence Monitoring Orthopedics
Early Cancer Screening
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Circulating Biomarker for Liquid Biopsy Market Overview 2018-2029
-
1.1 China Circulating Biomarker for Liquid Biopsy Industry Development Overview
-
1.2 China Circulating Biomarker for Liquid Biopsy Industry Development History
-
1.3 China Circulating Biomarker for Liquid Biopsy Industry Market Size (2018-2029)
-
1.4 China Circulating Biomarker for Liquid Biopsy Market Analysis by Type from Production Side
-
1.4.1 China Circulating Biomarker for Liquid Biopsy Production Volume, Production Value and Growth Rate of Cell-Free DNA (cfDNA) (2018-2029)
-
1.4.2 China Circulating Biomarker for Liquid Biopsy Production Volume, Production Value and Growth Rate of Circulating Tumor DNA (ctDNA) (2018-2029)
-
1.4.3 China Circulating Biomarker for Liquid Biopsy Production Volume, Production Value and Growth Rate of Extracellular Vesicles (EVs) (2018-2029)
-
1.4.4 China Circulating Biomarker for Liquid Biopsy Production Volume, Production Value and Growth Rate of Circulating Tumor Cells (CTCs) (2018-2029)
-
1.4.5 China Circulating Biomarker for Liquid Biopsy Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.5 China Circulating Biomarker for Liquid Biopsy Market Analysis by Application from Consumption End
-
1.5.1 China Circulating Biomarker for Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Treatment Monitoring (2018-2029)
-
1.5.2 China Circulating Biomarker for Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Therapy Selection (2018-2029)
-
1.5.3 China Circulating Biomarker for Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Recurrence Monitoring Orthopedics (2018-2029)
-
1.5.4 China Circulating Biomarker for Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Early Cancer Screening (2018-2029)
-
1.6 China Circulating Biomarker for Liquid Biopsy Market Analysis by Region
-
1.6.1 North China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
Chapter 2 China Circulating Biomarker for Liquid Biopsy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Circulating Biomarker for Liquid Biopsy Market Status and Competition at home and abroad in 2023
-
2.2.2 China Circulating Biomarker for Liquid Biopsy Market Status and Competition Analysis in 2023
-
2.2.3 China Circulating Biomarker for Liquid Biopsy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Circulating Biomarker for Liquid Biopsy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Circulating Biomarker for Liquid Biopsy Industry Development
Chapter 3 Circulating Biomarker for Liquid BiopsyIndustry Chain Analysis
-
3.1 Circulating Biomarker for Liquid Biopsy Industry Chain
-
3.2 Circulating Biomarker for Liquid Biopsy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Circulating Biomarker for Liquid Biopsy Market
-
3.3 Circulating Biomarker for Liquid Biopsy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Circulating Biomarker for Liquid Biopsy Market
Chapter 4 China Circulating Biomarker for Liquid Biopsy Market, by Type
-
4.1 China Circulating Biomarker for Liquid Biopsy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Circulating Biomarker for Liquid Biopsy Total Production Volume and Growth Rate from Production Side
-
4.5 China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate, by Type
-
4.5.1 China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate of Cell-Free DNA (cfDNA)
-
4.5.2 China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate of Circulating Tumor DNA (ctDNA)
-
4.5.3 China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate of Extracellular Vesicles (EVs)
-
4.5.4 China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate of Circulating Tumor Cells (CTCs)
-
4.5.5 China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate of Others
Chapter 5 China Circulating Biomarker for Liquid Biopsy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Circulating Biomarker for Liquid Biopsy Total Market Size and Growth Rate from Consumption End
-
5.5 China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate, by Application
-
5.5.1 China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate of Treatment Monitoring
-
5.5.2 China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate of Therapy Selection
-
5.5.3 China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate of Recurrence Monitoring Orthopedics
-
5.5.4 China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate of Early Cancer Screening
Chapter 6 China Circulating Biomarker for Liquid Biopsy Market, by Region
-
6.1 China Circulating Biomarker for Liquid Biopsy Production Volume and Production Value, by Region
-
6.2 China Circulating Biomarker for Liquid Biopsy Sales Volume and Sales Value, by Region
Chapter 7 North China Circulating Biomarker for Liquid Biopsy Market Analysis
-
7.1 North China Circulating Biomarker for Liquid Biopsy Market, by Type
-
7.2 North China Circulating Biomarker for Liquid Biopsy Market, by Application
Chapter 8 Central China Circulating Biomarker for Liquid Biopsy Market Analysis
-
8.1 Central China Circulating Biomarker for Liquid Biopsy Market, by Type
-
8.2 Central China Circulating Biomarker for Liquid Biopsy Market, by Application
Chapter 9 South China Circulating Biomarker for Liquid Biopsy Market Analysis
-
9.1 South China Circulating Biomarker for Liquid Biopsy Market, by Type
-
9.2 South China Circulating Biomarker for Liquid Biopsy Market, by Application
Chapter 10 East China Circulating Biomarker for Liquid Biopsy Market Analysis
-
10.1 East China Circulating Biomarker for Liquid Biopsy Market, by Type
-
10.2 East China Circulating Biomarker for Liquid Biopsy Market, by Application
Chapter 11 Northeast China Circulating Biomarker for Liquid Biopsy Market Analysis
-
11.1 Northeast China Circulating Biomarker for Liquid Biopsy Market, by Type
-
11.2 Northeast China Circulating Biomarker for Liquid Biopsy Market, by Application
Chapter 12 Southwest China Circulating Biomarker for Liquid Biopsy Market Analysis
-
12.1 Southwest China Circulating Biomarker for Liquid Biopsy Market, by Type
-
12.2 Southwest China Circulating Biomarker for Liquid Biopsy Market, by Application
Chapter 13 Northwest China Circulating Biomarker for Liquid Biopsy Market Analysis
-
13.1 Northwest China Circulating Biomarker for Liquid Biopsy Market, by Type
-
13.2 Northwest China Circulating Biomarker for Liquid Biopsy Market, by Application
Chapter 14 Company Profiles
-
14.1 Abbott Laboratories
-
14.1.1 Abbott Laboratories Company Profile
-
14.1.2 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Becton, Dickinson and Company
-
14.2.1 Becton, Dickinson and Company Company Profile
-
14.2.2 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Epigenomics AG
-
14.3.1 Epigenomics AG Company Profile
-
14.3.2 Epigenomics AG Circulating Biomarker for Liquid Biopsy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 GE Healthcare
-
14.4.1 GE Healthcare Company Profile
-
14.4.2 GE Healthcare Circulating Biomarker for Liquid Biopsy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Fluxion Biosciences
-
14.5.1 Fluxion Biosciences Company Profile
-
14.5.2 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Biocept
-
14.6.1 Biocept Company Profile
-
14.6.2 Biocept Circulating Biomarker for Liquid Biopsy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Affymetrix
-
14.7.1 Affymetrix Company Profile
-
14.7.2 Affymetrix Circulating Biomarker for Liquid Biopsy Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Circulating Biomarker for Liquid Biopsy Industry Research Conclusions
-
15.2 Circulating Biomarker for Liquid Biopsy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Circulating Biomarker for Liquid Biopsy Industry Market Size (2018-2029)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume, Production Value and Growth Rate of Cell-Free DNA (cfDNA) (2018-2029)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume, Production Value and Growth Rate of Circulating Tumor DNA (ctDNA) (2018-2029)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume, Production Value and Growth Rate of Extracellular Vesicles (EVs) (2018-2029)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume, Production Value and Growth Rate of Circulating Tumor Cells (CTCs) (2018-2029)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Circulating Biomarker for Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Treatment Monitoring (2018-2029)
-
Figure China Circulating Biomarker for Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Therapy Selection (2018-2029)
-
Figure China Circulating Biomarker for Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Recurrence Monitoring Orthopedics (2018-2029)
-
Figure China Circulating Biomarker for Liquid Biopsy Sales Volume, Sales Value and Growth Rate of Early Cancer Screening (2018-2029)
-
Figure North China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
Figure Central China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
Figure South China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
Figure East China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate from 2018-2029
-
Figure Circulating Biomarker for Liquid Biopsy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Circulating Biomarker for Liquid Biopsy Market Share by Type in 2018
-
Figure China Circulating Biomarker for Liquid Biopsy Market Share by Type in 2023
-
Figure China Circulating Biomarker for Liquid Biopsy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate of Cell-Free DNA (cfDNA) (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate of Circulating Tumor DNA (ctDNA) (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate of Extracellular Vesicles (EVs) (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate of Circulating Tumor Cells (CTCs) (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Market Share by Application in 2018
-
Figure China Circulating Biomarker for Liquid Biopsy Market Share by Application in 2023
-
Figure China Circulating Biomarker for Liquid Biopsy Total Market Size and Growth Rate from Consumption End
-
Figure China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate of Treatment Monitoring (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate of Therapy Selection (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate of Recurrence Monitoring Orthopedics (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Market Size and Growth Rate of Early Cancer Screening (2018-2023)
-
Table China Circulating Biomarker for Liquid Biopsy Production Volume by Region (2018-2023)
-
Table China Circulating Biomarker for Liquid Biopsy Production Volume Share by Region (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Volume Share by Region (2018-2023)
-
Table China Circulating Biomarker for Liquid Biopsy Production Value by Region (2018-2023)
-
Table China Circulating Biomarker for Liquid Biopsy Production Value Share by Region (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Production Value Share by Region (2018-2023)
-
Table China Circulating Biomarker for Liquid Biopsy Sales Volume by Region (2018-2023)
-
Table China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Region (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Region (2018-2023)
-
Table China Circulating Biomarker for Liquid Biopsy Sales Value by Region (2018-2023)
-
Table China Circulating Biomarker for Liquid Biopsy Sales Value Share by Region (2018-2023)
-
Figure China Circulating Biomarker for Liquid Biopsy Sales Value Share by Region (2018-2023)
-
Table North China Circulating Biomarker for Liquid Biopsy Production Volume by Type (2018-2023)
-
Table North China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Figure North China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Table North China Circulating Biomarker for Liquid Biopsy Sales Volume by Application (2018-2023)
-
Table North China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Figure North China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Table Central China Circulating Biomarker for Liquid Biopsy Production Volume by Type (2018-2023)
-
Table Central China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Figure Central China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Table Central China Circulating Biomarker for Liquid Biopsy Sales Volume by Application (2018-2023)
-
Table Central China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Figure Central China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Table South China Circulating Biomarker for Liquid Biopsy Production Volume by Type (2018-2023)
-
Table South China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Figure South China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Table South China Circulating Biomarker for Liquid Biopsy Sales Volume by Application (2018-2023)
-
Table South China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Figure South China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Table East China Circulating Biomarker for Liquid Biopsy Production Volume by Type (2018-2023)
-
Table East China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Figure East China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Table East China Circulating Biomarker for Liquid Biopsy Sales Volume by Application (2018-2023)
-
Table East China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Figure East China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Table Northeast China Circulating Biomarker for Liquid Biopsy Production Volume by Type (2018-2023)
-
Table Northeast China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Figure Northeast China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Table Northeast China Circulating Biomarker for Liquid Biopsy Sales Volume by Application (2018-2023)
-
Table Northeast China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Table Southwest China Circulating Biomarker for Liquid Biopsy Production Volume by Type (2018-2023)
-
Table Southwest China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Figure Southwest China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Table Southwest China Circulating Biomarker for Liquid Biopsy Sales Volume by Application (2018-2023)
-
Table Southwest China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Table Northwest China Circulating Biomarker for Liquid Biopsy Production Volume by Type (2018-2023)
-
Table Northwest China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Figure Northwest China Circulating Biomarker for Liquid Biopsy Production Volume Share by Type (2018-2023)
-
Table Northwest China Circulating Biomarker for Liquid Biopsy Sales Volume by Application (2018-2023)
-
Table Northwest China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Circulating Biomarker for Liquid Biopsy Sales Volume Share by Application (2018-2023)
-
Table Abbott Laboratories Company Profile
-
Table Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue, Price and Gross (2018-2023)
-
Table Becton, Dickinson and Company Company Profile
-
Table Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue, Price and Gross (2018-2023)
-
Table Epigenomics AG Company Profile
-
Table Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue, Price and Gross (2018-2023)
-
Table GE Healthcare Company Profile
-
Table GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue, Price and Gross (2018-2023)
-
Table Fluxion Biosciences Company Profile
-
Table Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue, Price and Gross (2018-2023)
-
Table Biocept Company Profile
-
Table Biocept Circulating Biomarker for Liquid Biopsy Revenue, Price and Gross (2018-2023)
-
Table Affymetrix Company Profile
-
Table Affymetrix Circulating Biomarker for Liquid Biopsy Revenue, Price and Gross (2018-2023)
-